SENIOR LEADERSHIP

7.1高级领导力 导演：C.Kent Osborne医学博士 奥斯本博士为担任癌症中心主任付出了6个月的努力。作为董事，他的职责包括： 1.监督北京中医药中心与癌症相关的临床和研究活动。 2.促进跨学科协调协作。 3.促进与其他医疗机构和癌症中心的互动和合作。 4.组织和监督癌症中心的共享资源，创建新的共享资源，或根据需要消除过时的资源，以最好地执行癌症中心的使命和目标。 5.制定和管理癌症中心的预算及其慈善捐赠。 6.与系主任合作招募新的教员，以加强癌症中心的使命。 7.分配癌症中心空间，批准会员申请，并在学院学术委员会和贝勒诊所执行委员会代表癌症中心。 奥斯本博士是达德利和蒂娜·夏普癌症研究中心的主席，也是乳房中心的主任。他于1972年在密苏里大学医学院获得医学博士学位，随后在约翰霍普金斯大学接受内科培训，并在国家癌症研究所获得内科肿瘤学奖学金。 1977年，他搬到了圣安东尼奥的德克萨斯大学健康科学中心，在那里，他和他已故的同事，医学博士威廉·麦奎尔建立了一个国际公认的乳腺癌项目。奥斯本博士晋升为医学教授和肿瘤科主任，并担任该机构癌症中心乳腺癌项目的项目负责人。1999年，他和他的团队搬到了贝勒学院 在休斯顿创建乳房中心的医学。奥斯本博士是一名董事会认证的肿瘤学家，专门研究乳腺癌已超过25年。他也是一位公认的翻译科学家，他的实验室自1978年以来一直得到资助。他在雌激素受体功能、抵抗内分泌治疗的机制以及ER和生长因子受体通路之间的串扰方面的工作得到了认可。在他的职业生涯中，他发表了300多本出版物，并因其研究获得了许多奖项。奥斯本博士一直是乳腺癌项目赠款项目的首席研究员，该项目自1980年以来一直得到资助。他也是乳腺癌孢子赠款的首席研究员，该基金自1992年以来一直得到资助。他已经将PPG首席调查员的角色让给了一位同事，以便能够有更多的时间来指导癌症中心。他还会继续 在PPG的研究计划中有一个罗伊。 奥斯本博士拥有丰富的行政经验。他曾担任西南肿瘤学小组乳房委员会主席多年，也是小组间乳房委员会的创始成员之一，该委员会负责监督在美国进行的主要3期乳腺癌试验。他曾在圣安东尼奥的德克萨斯大学健康科学中心担任肿瘤科主任7年 搬到休斯顿去当乳房中心主任。他曾在许多地方、国家和国际委员会任职，17年来一直担任圣安东尼奥乳腺癌研讨会的联合主任，这是致力于乳腺癌研究的最大年度研讨会，目前吸引了来自80多个国家的9000多名与会者。他之前曾担任西南肿瘤学集团的执行主任。他在1992-1995年间担任美国临床肿瘤学会董事会成员，并在1994-1997年间担任执行委员会成员。奥斯本博士曾在几个癌症中心的外部顾问委员会任职，并是NIH生殖内分泌学研究部的成员。

7.1 Senior Leadership Director: C. Kent Osborne M.D. Dr Osborne has committed 6.00 calendar months effort to serve as Cancer Center Director. As Director his responsibilities include: 1. Oversee cancer-related clinical and research activities at BCMCC. 2. Promote interdisciplinary coordination and collaboration. 3. Facilitate interactions and collaborations with other medical institutions and cancer centers. 4. Organize and oversee the Shared Resources ofthe Cancer Center, create new Shared Resources, or eliminate obsolete Resources as necessary to best carry out the Cancer Center's mission and goals. 5. Develop and manage the Cancer Center's budget and its philanthropic gifts. 6. Recruit new faculty in cooperation with Department Chairs to enhance the mission of the Cancer Center. 7. Allocate Cancer Center space, approve membership applications, and represent the Cancer Center on the College's Academic Council and on the Executive Committee ofthe Baylor Clinic. Dr. Osborne holds the Dudley and Tina Sharp Chair for Cancer Research and is also the Director of the Breast Center. He received his M.D. degree from the University of Missouri School of Medicine in 1972, followed by internal medicine training at Johns Hopkins, and a medical oncology fellowship at the National Cancer Institute. He then moved to the University of Texas Health Science Center at San Antonio in 1977 where he and his late colleague, William McGuire, M.D., built an internationally recognized breast cancer program. Dr. Osborne rose to be Professor of Medicine and the Director of the Division of Oncology and Program Leader of the Breast Cancer Program at the Cancer Center at that institution. In 1999, he and his group moved to Baylor College of Medicine to create a Breast Center in Houston. Dr. Osborne is a Board Certified Medical Oncologist who has been specializing in breast cancer for more than 25 years. He is also a well recognized translational scientist, and his laboratory has been continuously funded since 1978. He is recognized for his work on estrogen receptor function, mechanisms of resistance to endocrine therapy, and crosstalk between ER and growth factor receptor pathways. He has more than 300 publications in his career and has received many awards for his research. Dr. Osborne has been the principal investigator of a Program Project Grant in breast cancer that has been continuously funded since 1980. He is also the principal investigator on a breast cancer SPORE grant that has been continuously funded since 1992. He has relinquished his role as principal investigator of the PPG to a colleague in order to be able to devote more time to directing the Cancer Center. He will still have a roie in the research program of the PPG. Dr. Osborne has considerable administrative experience. He was chair of the Breast Committee for the Southwest Oncology Group for many years and was one of the founding members of the Intergroup Breast Committee, which oversees the major phase 3 breast cancer trials performed in this country. He was the Director of the Division of Medical Oncology at the UT Health Science Center at San Antonio for 7 years prior to moving to Houston to become Director of the Breast Center. He has served on numerous local, national, and international committees, and for 17 years has been co-director of the San Antonio Breast Cancer Symposium, the largest annual symposium devoted to breast cancer research, now attracting more than 9000 attendees from over 80 countries. He previously served as Executive Officer for the Southwest Oncology Group. He was a member of the American Society of Clinical Oncology Board of Directors from 1992-1995 and their Executive Committee from 1994-1997. Dr. Osborne has served on the External Advisory Boards of several Cancer Centers and was a member of the NIH Reproductive Endocrinology Study Section.